|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
15,030,000 |
Market
Cap: |
26.00(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.28 - $2.85 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Rafael Holdings holds interests in clinical and early stage pharmaceutical companies and commercial real estate assets. Co. has an investment in Rafael Pharmaceuticals, Inc., a late-stage cancer metabolism-based therapeutics company. In addition, Co. has established the Barer Institute as an early-stage small molecule research institute that develops therapeutic compounds, including compounds to regulate cancer metabolism with application in other indications beyond cancer. Co. also holds a majority equity interest in LipoMedix Pharmaceuticals Ltd., a clinical stage oncological pharmaceutical company based in Israel. Co.'s commercial real estate holdings include the building in Newark, NJ.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
13,080,457 |
13,080,457 |
13,080,457 |
13,080,457 |
Total Buy Value |
$16,742,985 |
$16,742,985 |
$16,742,985 |
$16,742,985 |
Total People Bought |
1 |
1 |
1 |
1 |
Total Buy Transactions |
1 |
1 |
1 |
1 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Polinsky David |
Chief Financial Officer |
|
2025-06-21 |
4 |
D |
$1.60 |
$3,743 |
D/D |
(2,347) |
268,075 |
|
- |
|
Jonas Howard S |
Exec Chairman, CEO & President |
|
2025-06-13 |
4 |
A |
$2.11 |
$250,000 |
D/D |
118,596 |
277,612 |
|
- |
|
Jonas Howard S |
Exec Chairman, CEO & President |
|
2025-06-05 |
4 |
B |
$1.28 |
$16,742,985 |
I/I |
13,080,457 |
12,299,207 |
0.01 |
3% |
|
Polinsky David |
Chief Financial Officer |
|
2025-05-29 |
4 |
OE |
$1.28 |
$98,409 |
D/D |
76,882 |
270,422 |
|
- |
|
Sieger Markus |
|
|
2025-05-27 |
4 |
OE |
$1.28 |
$44,800 |
D/D |
35,000 |
190,182 |
|
- |
|
Conkling William |
Chief Executive Officer |
|
2025-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
27,454 |
564,455 |
|
- |
|
Sieger Markus |
|
|
2025-03-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
155,182 |
|
-19% |
|
Polinsky David |
Chief Financial Officer |
|
2025-03-21 |
4 |
D |
$1.93 |
$4,590 |
D/D |
(2,378) |
193,540 |
|
- |
|
Conkling William |
Chief Executive Officer |
|
2025-03-21 |
4 |
D |
$1.93 |
$28,591 |
D/D |
(14,814) |
537,001 |
|
- |
|
Conkling William |
Chief Executive Officer |
|
2025-01-13 |
4 |
A |
$1.95 |
$117,240 |
D/D |
60,000 |
551,815 |
|
- |
|
Goldberg John |
CHIEF MEDICAL OFFICER |
|
2025-01-13 |
4 |
A |
$1.95 |
$97,700 |
D/D |
50,000 |
50,000 |
|
- |
|
Polinsky David |
Chief Financial Officer |
|
2025-01-13 |
4 |
A |
$1.95 |
$97,700 |
D/D |
50,000 |
195,918 |
|
- |
|
Greenberg Stephen M |
|
|
2025-01-06 |
4 |
A |
$1.82 |
$50,125 |
D/D |
27,541 |
102,491 |
|
- |
|
Weiss Michael J |
|
|
2025-01-06 |
4 |
A |
$1.82 |
$50,125 |
D/D |
27,541 |
102,491 |
|
- |
|
Stein Mark N |
|
|
2025-01-06 |
4 |
A |
$1.82 |
$20,885 |
D/D |
11,475 |
11,475 |
|
- |
|
Polinsky David |
Chief Financial Officer |
|
2024-12-21 |
4 |
D |
$1.84 |
$3,674 |
D/D |
(2,002) |
145,918 |
|
- |
|
Conkling William |
Chief Executive Officer |
|
2024-12-21 |
4 |
D |
$1.84 |
$23,501 |
D/D |
(12,807) |
491,815 |
|
- |
|
Conkling William |
Chief Executive Officer |
|
2024-10-25 |
4 |
D |
$1.84 |
$6,313 |
D/D |
(3,431) |
504,622 |
|
- |
|
Polinsky David |
Chief Financial Officer |
|
2024-10-25 |
4 |
D |
$1.84 |
$6,129 |
D/D |
(3,331) |
147,920 |
|
- |
|
Polinsky David |
Chief Financial Officer |
|
2024-09-23 |
4 |
D |
$1.73 |
$2,468 |
D/D |
(1,431) |
151,251 |
|
- |
|
Conkling William |
Chief Executive Officer |
|
2024-09-21 |
4 |
D |
$1.73 |
$21,901 |
D/D |
(12,696) |
508,053 |
|
- |
|
Polinsky David |
Chief Financial Officer |
|
2024-09-21 |
4 |
D |
$1.73 |
$4,112 |
D/D |
(2,384) |
152,682 |
|
- |
|
Jonas Howard S |
Executive Chairman |
|
2024-07-24 |
4 |
A |
$0.00 |
$0 |
I/I |
563,538 |
563,538 |
|
- |
|
Jonas Howard S |
Executive Chairman |
|
2024-07-24 |
4 |
D |
$0.00 |
$0 |
I/I |
(563,538) |
0 |
|
- |
|
Jonas Howard S |
Executive Chairman |
|
2024-06-26 |
4 |
A |
$0.00 |
$0 |
I/I |
563,538 |
563,538 |
|
- |
|
110 Records found
|
|
Page 1 of 5 |
|
|